Reuters logo
BRIEF-ThromboGenics cash 168.6 mln eur at end Q3
November 8, 2012 / 4:53 PM / in 5 years

BRIEF-ThromboGenics cash 168.6 mln eur at end Q3

BRUSSELS, Nov 8 (Reuters) - Thrombogenics NV : * Says has EUR 168.6 million eur in cash as of 30 September versus EUR 88.3

million at the end of September 2011 * 9-mnth revenue 75.1 million euros versus 2.5 million EUR last time * Sees Jetrea launch in January 2013

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below